Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 8.42% | 419.05 | 0.0% | $8674.93m | |
| BNTX | BioNTech SE | 17.80% | 414.44 | 0.0% | $1709.63m | |
| NVAX | Novavax, Inc. | 18.69% | 223.81 | 79.8% | $898.59m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.92% | 10.72 | 0.7% | $749.37m | |
| AMGN | Amgen, Inc. | -6.46% | 228.31 | 1.3% | $524.03m | |
| BIIB | Biogen, Inc. | 0.03% | 338.10 | 1.7% | $451.97m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.23% | 199.59 | 1.9% | $424.11m | |
| GILD | Gilead Sciences, Inc. | -0.85% | 69.24 | 1.0% | $409.81m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.95% | 580.95 | 2.7% | $330.19m | |
| ILMN | Illumina, Inc. | 1.24% | 504.60 | 3.5% | $271.58m | |
| NTLA | Intellia Therapeutics, Inc. | 5.87% | 146.94 | 2.3% | $204.93m | |
| SGEN | Seagen Inc. | 3.17% | 163.21 | 5.8% | $137.56m | |
| CRSP | CRISPR Therapeutics AG | 2.63% | 124.61 | 0.6% | $137.02m | |
| TBIO | Translate Bio, Inc. | 0.48% | 37.85 | 3.3% | $134.82m | |
| EXAS | EXACT Sciences Corp. | 1.56% | 105.83 | 18.1% | $131.45m |
Company Profile
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.